Annual Long Term Debt
$316.00 K
+$225.00 K+247.25%
31 December 2023
Summary:
Chemomab Therapeutics annual long term debt is currently $316.00 thousand, with the most recent change of +$225.00 thousand (+247.25%) on 31 December 2023. During the last 3 years, it has fallen by -$42.00 thousand (-11.73%). CMMB annual long term debt is now -11.73% below its all-time high of $358.00 thousand, reached on 31 December 2020.CMMB Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$230.00 K
-$21.00 K-8.37%
01 September 2024
Summary:
Chemomab Therapeutics quarterly long term debt is currently $230.00 thousand, with the most recent change of -$21.00 thousand (-8.37%) on 01 September 2024. CMMB quarterly long term debt is now -35.75% below its all-time high of $358.00 thousand, reached on 31 December 2020.CMMB Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMMB Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +247.3% | - |
| 3 y3 years | -11.7% | -22.8% |
| 5 y5 years | - | - |
CMMB Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -11.7% | +247.3% | -27.2% | +597.0% |
| 5 y | 5 years | -11.7% | +247.3% | -35.8% | +597.0% |
| alltime | all time | -11.7% | +247.3% | -35.8% | +597.0% |
Chemomab Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $230.00 K(-8.4%) |
| June 2024 | - | $251.00 K(-10.4%) |
| Mar 2024 | - | $280.00 K(-11.4%) |
| Dec 2023 | $316.00 K(+247.3%) | $316.00 K(+857.6%) |
| June 2023 | - | $33.00 K(-46.8%) |
| Mar 2023 | - | $62.00 K(-31.9%) |
| Dec 2022 | $91.00 K | $91.00 K(-22.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $118.00 K(-20.3%) |
| June 2022 | - | $148.00 K(-27.1%) |
| Mar 2022 | - | $203.00 K(-14.3%) |
| Dec 2021 | $237.00 K(-33.8%) | $237.00 K(-20.5%) |
| Sept 2021 | - | $298.00 K(-6.9%) |
| June 2021 | - | $320.00 K(-2.4%) |
| Mar 2021 | - | $328.00 K(-8.4%) |
| Dec 2020 | $358.00 K | $358.00 K |
FAQ
- What is Chemomab Therapeutics annual long term debt?
- What is the all time high annual long term debt for Chemomab Therapeutics?
- What is Chemomab Therapeutics annual long term debt year-on-year change?
- What is Chemomab Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Chemomab Therapeutics?
What is Chemomab Therapeutics annual long term debt?
The current annual long term debt of CMMB is $316.00 K
What is the all time high annual long term debt for Chemomab Therapeutics?
Chemomab Therapeutics all-time high annual long term debt is $358.00 K
What is Chemomab Therapeutics annual long term debt year-on-year change?
Over the past year, CMMB annual long term debt has changed by +$225.00 K (+247.25%)
What is Chemomab Therapeutics quarterly long term debt?
The current quarterly long term debt of CMMB is $230.00 K
What is the all time high quarterly long term debt for Chemomab Therapeutics?
Chemomab Therapeutics all-time high quarterly long term debt is $358.00 K